𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes

✍ Scribed by Christopher M. Heaphy; Andrea P. Subhawong; Seung-Mo Hong; Michael G. Goggins; Elizabeth A. Montgomery; Edward Gabrielson; George J. Netto; Jonathan I. Epstein; Tamara L. Lotan; William H. Westra; Ie-Ming Shih; Christine A. Iacobuzio-Donahue; Anirban Maitra; Qing K. Li; Charles G. Eberhart; Janis M. Taube; Dinesh Rakheja; Robert J. Kurman; T.C. Wu; Richard B. Roden; Pedram Argani; Angelo M. De Marzo; Luigi Terracciano; Michael Torbenson; Alan K. Meeker

Book ID
116203361
Publisher
American Society for Investigative Pathology
Year
2011
Tongue
English
Weight
730 KB
Volume
179
Category
Article
ISSN
0002-9440

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Telomere maintenance in wilms tumors: Fi
Telomere maintenance in wilms tumors: First evidence for the presence of alternative lengthening of telomeres mechanism
✍ Lorenza Venturini; Maria Grazia Daidone; Rosita Motta; Paola Collini; Filippo Sp πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 486 KB

## Abstract Unlimited proliferative potential is a hallmark of cancer, and can be achieved through the activation of telomere maintenance mechanisms (TMMs). Most tumors activate telomerase, but a significant minority, mainly of mesenchymal origin, uses a recombination‐based, alternative lengthening

Divergent patterns of telomere maintenan
Divergent patterns of telomere maintenance mechanisms among human sarcomas: Sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas
✍ Gary A. Ulaner; Andrew R. Hoffman; Jesse Otero; Hsuan-Ying Huang; Zhiquan Zhao; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 155 KB

## Abstract Two types of telomere maintenance mechanisms (TMMs) have been described in human tumors: telomerase activation and alternative lengthening of telomeres (ALT). Although the vast majority of epithelial tumors rely on telomerase activation, many mesenchymal tumors rely on ALT for telomere